Drug Resistance of Clinical Varicella-Zoster Virus Strains Confirmed by Recombinant Thymidine Kinase Expression and by Targeted Resistance Mutagenesis of a Cloned Wild-Type Isolate

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.05115-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Discriminating Between Varicella-Zoster Virus Vaccine and Wild-Type Strains by Loop-Mediated Isothermal Amplification

Journal of Clinical Microbiology
Microbiology
2008English

Recombinant Varicella-Zoster Virus Vaccines as Platforms for Expression of Foreign Antigens

Advances in Virology
VirologyInfectious Diseases
2013English

Clinical Features of Varicella-Zoster Virus Infection

Viruses
VirologyInfectious Diseases
2018English

Clinical and Molecular Aspects of Varicella Zoster Virus Infection

Future Neurology
Neurology
2009English

Varicella-Zoster Virus ORF47 Protein Serine Kinase: Characterization of a Cloned, Biologically Active Phosphotransferase and Two Viral Substrates, ORF62 and ORF63

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

nfxC-type Quinolone Resistance in a Clinical Isolate of Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Two Cases of Laryngeal Palsy Caused by Varicella-Zoster Virus

Practica Otologica
Otorhinolaryngology
2003English

A Rapid Phenotypic Assay for Detection of Acyclovir-Resistant Varicella-Zoster Virus With Mutations in the Thymidine Kinase Open Reading Frame

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Complementation of a Herpes Simplex Virus ICP0 Null Mutant by Varicella-Zoster Virus ORF61p

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy